skin cancer

New target could predict melanomaNew information could eventually help identify a high-risk population before they get cancer — even prevent skin cancer’s onset.
First do no Mohs harmAn expert advises evaluating each patient’s surrounding circumstances when determining whether Mohs surgery is indicated.
How to weigh benefit of Moh'sMohs surgery experts advise when Mohs is and isn’t optimal skin cancer treatment.
EWG releases 2016 sunscreen recommendationsEWG, which focuses on consumer and environmental health, claims that 72 percent of 750 available sunscreens the group evaluated offer inferior protection or contain ingredients that could harm skin. Some pediatric dermatologists weigh in.
Scientists gain new insight into UV-exposure geneticsXeroderma pigmentosum is a rare disease that leads to early skin cancer. New insights may lead to better prevention and survival for patients, as well as point to ways that UV-resistant gene functions could be used for skin cancer prevention and treatment.
Gene tests predicts melanoma stagingA gene expression profile test rivals sentinel node biopsy in predicting distant metastasis in stage 1 and stage 2 melanoma, according to results from a new multicenter performance study.
Light-listening device could transform skin disease detectionThe future of skin cancer and other disease detection could change with the development of a photonics device that listens to light.
Dermatologists take a hike in the name of skin cancer
Dermatologists take a hike in the name of skin cancerDermatologists attending the annual meeting for the Florida Society of Dermatology and Dermatologic Surgery, in Naples, took a break from meeting sessions and presentations to hike a three-mile stretch of the beach wearing sun protective clothes and sunscreen, and talking with beachgoers about skin cancer recognition and prevention.
New compounds may block melanoma tumor growthEarly study results indicate the potential for a new class of inhibitory compounds to enhance the effect of anti-tumor drugs in melanoma treatment. What the future may hold.
Immune checkpoint inhibitors advance melanoma treatmentWhile much progress has been made since interleukin-2 was used to treat melanoma, physicians are still weighing the advantages and disadvantages of monotherapy versus combination therapies.